leadf
logo-loader
viewTelix Pharmaceuticals Ltd

Telix Pharmaceuticals with Proactive at the ASX Small and Mid-Cap Conference 2020

Telix Pharmaceuticals Ltd's (ASX:TLX) Christian Behrenbruch speaks with Proactive's Andrew Scott at the virtual ASX Small and Mid-Cap Conference 2020. They're a Melbourne-headquartered global biopharmaceutical company focused on the development of diagnostic and therapeutic products based on targeted radiopharmaceuticals or molecularly targeted radiation.

Quick facts: Telix Pharmaceuticals Ltd

Price: 1.8 AUD

ASX:TLX
Market: ASX
Market Cap: $457.1 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Davide Bosio previews hotly anticipated IPOs for Miramar Resources and Zebit

Davide Bosio from Shaw and Partners says it's been a terrific start to the listing process for Miramar Resources, a junior West Australia exploration company. ''We opened up the offer and closed literally on the same day raising $8mln''. Bosio adds that Zebit is still on track to list on the ASX...

1 day, 15 hours ago

2 min read